HB-adjuvants

HB-adjuvants is a biotechnology company focused on the development of novel vaccine adjuvants, particularly for Hepatitis B and other infectious diseases. The company leverages its proprietary platform to enhance the immune response to vaccine antigens, aiming to improve vaccine efficacy and durability. HB-adjuvants provides specialized solutions for both human and animal health, offering a range of immunostimulators and delivery systems. Their technology is designed to activate specific immune pathways, facilitating the development of next-generation vaccines. The company is actively involved in research and development to address global health challenges through innovative adjuvant systems.